We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC FIRMS OBJECT TO DRUG 'CARVE OUT' INITIATIVES
GENERIC FIRMS OBJECT TO DRUG 'CARVE OUT' INITIATIVES
April 16, 2004
The brand pharmaceutical lobby has succeeded in persuading lawmakers in almost half the states to amend Medicaid laws to exempt expensive therapeutic drug classes from substitution rules requiring doctors to prescribe lower-priced alternatives, according to one generic drug executive.